SMAD4 and hepatocellular carcinoma: Yang et al. confirmed that Smad4 deletion in hepatocytes after knocking out TAK1 inhibited the apoptosis of hepatocytes and decreased serum ALT levels, while it simultaneously alleviated liver inflammation, fibrosis, and HCC [17].